A resolution to declare May 5-9, 2025, as Tardive Dyskinesia Awareness Week in the state of Michigan.

2025-2026 Regular Session Introduced by John Fitzgerald and 5 co-sponsors

Declares May 5–9, 2025 as Michigan TD Awareness Week to boost screening, education, and awareness among patients on antipsychotics, clinicians, and care partners.

adopted

Purpose

HR 82 is a non‑binding House resolution that declares May 5–9, 2025, as Tardive Dyskinesia (TD) Awareness Week in the state of Michigan. Its stated intent is to raise public and clinical awareness of TD, encourage routine screening and early detection, and highlight available treatment options to improve outcomes for people taking antipsychotic medications.

Key provisions and findings (from the resolution)

Declares May 5–9, 2025, as Tardive Dyskinesia Awareness Week in Michigan.

Summarizes TD as an involuntary movement disorder associated with prolonged antipsychotic use, characterized by repetitive, uncontrollable movements of the face, torso, limbs, or extremities.

Notes estimated U.S. prevalence and diagnosis gaps: about 800,000 U.S. adults may be living with TD and roughly 60% remain undiagnosed.

Identifies higher‑risk groups: people older than 55, Black individuals, women, persons with mood or substance‑use disorders, intellectual disabilities, central nervous system injuries, and those with high cumulative antipsychotic exposure.

Cites clinical guidance: the American Psychiatric Association recommends routine TD screening for patients treated with antipsychotics.

Observes that FDA‑approved treatments exist that can help manage TD symptoms.

Encourages TD screening education and awareness among health care providers, patients, and care partners.

Who is affected

Primary focus: patients in Michigan who are prescribed antipsychotic medications (for schizophrenia, bipolar disorder, major depressive disorder, etc.), their care partners, and clinicians who prescribe/monitor antipsychotic therapy.

Secondary effects: public health educators, mental‑health advocacy groups, and health systems that may use the awareness week to promote screening, education and support services.

Impact and limitations

Practical impact: symbolic — raises awareness and encourages best practices (screening, consultation, education), but does not create new legal requirements, funding, or programs.

Potential downstream effects: may prompt health systems, professional groups, and advocacy organizations to organize outreach, screening initiatives, or educational activities during the designated week.

Procedural status and sponsors

Status: Adopted by the Michigan House (final status listed as “adopted”).

Date declared for awareness week: May 5–9, 2025.

Primary sponsor: Representative Curtis VanderWall (resolution text also lists several Michigan House members as co‑sponsors in adopted version).

Related measure: HCR 88 (companion).

Note: As a House resolution, HR 82 is ceremonial and intended to raise awareness rather than change statutes or appropriate funds.

Bill